Description

The global real-world evidence solutions market is poised to grow by US$ 1,261.7 million from 2022 to 2028, registering a CAGR of 13.5% during the forecast period, according to StrategyHelix.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for real-world evidence solutions. The global real-world evidence solutions market is segmented on the basis of component, therapeutic area, end user, and region. By component, the global real-world evidence solutions market has been segmented into data sets, services. Based upon therapeutic area, the global real-world evidence solutions market is categorized into cardiovascular disease, immunology, neurology, oncology, others. On the basis of end user, the global real-world evidence solutions market has been segmented into healthcare payers, healthcare providers, pharmaceutical & medical device companies, others. In terms of geography, the global real-world evidence solutions market has been segmented into North America, Europe, Asia-Pacific, Rest of the World.

The global real-world evidence solutions market is highly competitive. Top players covered in Global Real-World Evidence Solutions Market Study are Accenture plc, Clinigen Group Plc, COTA Inc., IBM Corporation, ICON plc, IQVIA Inc., Optum Inc., Oracle Corporation, Parexel International Corporation, PerkinElmer Inc., PPD Inc., Saama Technologies LLC., SAS Institute Inc., Syneos Health Inc., Tempus Labs Inc.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the real-world evidence solutions market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Component: data sets, services
Therapeutic area: cardiovascular disease, immunology, neurology, oncology, others
End user: healthcare payers, healthcare providers, pharmaceutical & medical device companies, others
Region: North America, Europe, Asia-Pacific, Rest of the World
Years considered: this report covers the period 2018 to 2028

Key Benefits for Stakeholders

– Get a comprehensive picture of the global real-world evidence solutions market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Real-world evidence solutions market overview
Part 3. Market breakdown by component
– Data sets
– Services
Part 4. Market breakdown by therapeutic area
– Cardiovascular disease
– Immunology
– Neurology
– Oncology
– Others
Part 5. Market breakdown by end user
– Healthcare payers
– Healthcare providers
– Pharmaceutical & medical device companies
– Others
Part 6. Market breakdown by region
– North America
– Europe
– Asia-Pacific
– Rest of the World
Part 7. Key companies
– Accenture plc
– Clinigen Group Plc
– COTA, Inc.
– IBM Corporation
– ICON plc
– IQVIA Inc.
– Optum, Inc.
– Oracle Corporation
– Parexel International Corporation
– PerkinElmer, Inc.
– PPD, Inc.
– Saama Technologies, LLC.
– SAS Institute, Inc.
– Syneos Health, Inc.
– Tempus Labs, Inc.
About StrategyHelix
Disclaimer